Estrella Immunopharma Stock Analysis
| ESLAW Stock | 0.10 0.01 9.09% |
Estrella Immunopharma is overvalued with Real Value of 0.0756 and Hype Value of 0.1. The main objective of Estrella Immunopharma stock analysis is to determine its intrinsic value, which is an estimate of what Estrella Immunopharma is worth, separate from its market price. There are two main types of Estrella Immunopharma's stock analysis: fundamental analysis and technical analysis.
The Estrella Immunopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Estrella Immunopharma is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Estrella Stock trading window is adjusted to America/New York timezone.
Estrella |
Estrella Stock Analysis Notes
The company had not issued any dividends in recent years. To learn more about Estrella Immunopharma call Cheng Liu at 510 318 9098 or check out https://www.estrellabio.com.Estrella Immunopharma Investment Alerts
| Estrella Immunopharma is way too risky over 90 days horizon | |
| Estrella Immunopharma has some characteristics of a very speculative penny stock | |
| Estrella Immunopharma appears to be risky and price may revert if volatility continues | |
| Estrella Immunopharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Estrella Immunopharma generates negative cash flow from operations | |
| Estrella Immunopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Estrella Immunopharma, Inc. Receives Buy Rating with a 12-Month Price Target of 16.00 from D. Boral Capital |
Estrella Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.10) | (0.10) | |
| Return On Capital Employed | (0.18) | (0.18) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.14) | (0.15) |
Management Efficiency
The company has return on total asset (ROA) of (1.7475) % which means that it has lost $1.7475 on every $100 spent on assets. This is way below average. Estrella Immunopharma's management efficiency ratios could be used to measure how well Estrella Immunopharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.1 in 2025. Return On Capital Employed is likely to drop to -0.18 in 2025. At this time, Estrella Immunopharma's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 302.3 K in 2025, whereas Non Current Assets Total are likely to drop 0.00 in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.23 | 1.29 | |
| Tangible Book Value Per Share | 1.23 | 1.29 | |
| Enterprise Value Over EBITDA | (65.28) | (68.54) | |
| Price Book Value Ratio | 8.39 | 8.81 | |
| Enterprise Value Multiple | (65.28) | (68.54) | |
| Price Fair Value | 8.39 | 8.81 | |
| Enterprise Value | 59.8 M | 51.9 M |
Evaluating the management effectiveness of Estrella Immunopharma allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Estrella Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Technical Drivers
As of the 26th of February, Estrella Immunopharma shows the Mean Deviation of 21.1, downside deviation of 25.85, and Coefficient Of Variation of 650.91. Estrella Immunopharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Estrella Immunopharma variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Estrella Immunopharma is priced favorably, providing market reflects its regular price of 0.1 per share. As Estrella Immunopharma appears to be a penny stock we also advise to verify its total risk alpha numbers.Estrella Immunopharma Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Estrella Immunopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Estrella Immunopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Estrella Immunopharma Predictive Daily Indicators
Estrella Immunopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Estrella Immunopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Estrella Immunopharma Forecast Models
Estrella Immunopharma's time-series forecasting models are one of many Estrella Immunopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Estrella Immunopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Estrella Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Estrella Immunopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Estrella shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Estrella Immunopharma. By using and applying Estrella Stock analysis, traders can create a robust methodology for identifying Estrella entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Estrella Immunopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Additional Tools for Estrella Stock Analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.